Literature DB >> 22433450

Association between the NMDA glutamate receptor GRIN2B gene and obsessive-compulsive disorder.

Pino Alonso1, Mónica Gratacós, Cinto Segalàs, Georgia Escaramís, Eva Real, Mónica Bayés, Javier Labad, Clara López-Solà, Xavier Estivill, José M Menchón.   

Abstract

BACKGROUND: Recent data from neuroimaging, genetic and clinical trials and animal models suggest a role for altered glutamatergic neuro transmission in the pathogenesis of obsessive-compulsive disorder (OCD). The aim of this study was to investigate whether variants in the GRIN2B gene, the gene encoding the NR2 subunit of the N-methyl-D-aspartate (NMDA) glutamate receptor, may contribute to genetic susceptibility to OCD or to different OCD subphenotypes.
METHODS: Between 2003 and 2008, we performed a case-control association study in which we genotyped 10 tag single-nucleotide polymorphisms (SNPs) in the 3' untranslated region (3' UTR) of GRIN2B. We performed SNP association and haplotype analysis considering the OCD diagnosis and different OCD subphenotypes: early-onset OCD, comorbid tic disorders and OCD clinical symptom dimensions.
RESULTS: We enrolled 225 patients with OCD and 279 controls recruited from the OCD Clinic at Bellvitge Hospital (Barcelona, Spain). No significant difference in the distribution of alleles or genotypes was detected between patients with OCD and controls. Nonetheless, on analyzing OCD subphenotypes, the rs1805476 SNP in male patients (95% confidence interval [CI] 1.37-4.22, p = 0.002) and a 4-SNP haplotype in the whole sample (rs1805476, rs1805501, rs1805502 and rs1805477; odds ratio 1.92, 95% CI 1.22-3.01; permutation p = 0.023) were significantly associated with the presence of contamination obsessions and cleaning compulsions. LIMITATIONS: Study limitations included the risk of population stratification associated with the case-control design, use of psychiatrically unscreened blood donors as the control group, reduced sample size of participants with certain OCD subphenotypes and tested polymorphisms limited to 3' UTR and exon 13 of GRIN2B.
CONCLUSION: Our results converge with recent data suggesting a possible contribution of glutamatergic variants to the genetic vulnerability to OCD or at least to certain OCD manifestations. The dissection of OCD into more homogeneous subphenotypes may constitute a useful tool to disentangle the complex genetic basis of the disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22433450      PMCID: PMC3380099          DOI: 10.1503/jpn.110109

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  60 in total

1.  The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions.

Authors:  M C Rosario-Campos; E C Miguel; S Quatrano; P Chacon; Y Ferrao; D Findley; L Katsovich; L Scahill; R A King; S R Woody; D Tolin; E Hollander; Y Kano; J F Leckman
Journal:  Mol Psychiatry       Date:  2006-05       Impact factor: 15.992

2.  Gender-related differences among Turkish patients with obsessive-compulsive disorder.

Authors:  Raşit Tükel; Aslihan Polat; Aysun Genç; Oya Bozkurt; Hatice Atli
Journal:  Compr Psychiatry       Date:  2004 Sep-Oct       Impact factor: 3.735

3.  A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry.

Authors:  E J Nordstrom; F H Burton
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

4.  Association of the SLC1A1 glutamate transporter gene and obsessive-compulsive disorder.

Authors:  S Evelyn Stewart; Jesen A Fagerness; Jill Platko; Jordan W Smoller; Jeremiah M Scharf; Cornelia Illmann; Eric Jenike; Nadia Chabane; Marion Leboyer; Richard Delorme; Michael A Jenike; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2007-12-05       Impact factor: 3.568

5.  NMDA receptor type 2D gene as target for estrogen receptor in the brain.

Authors:  T Watanabe; S Inoue; H Hiroi; A Orimo; M Muramatsu
Journal:  Brain Res Mol Brain Res       Date:  1999-01-08

6.  Obsessive-compulsive symptom dimensions in affected sibling pairs diagnosed with Gilles de la Tourette syndrome.

Authors:  James F Leckman; David L Pauls; Heping Zhang; Maria C Rosario-Campos; Liliya Katsovich; Kenneth K Kidd; Andrew J Pakstis; John P Alsobrook; Mary M Robertson; William M McMahon; John T Walkup; Ben J M van de Wetering; Robert A King; Donald J Cohen
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-01-01       Impact factor: 3.568

7.  Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder.

Authors:  Richard Delorme; Marie-Odile Krebs; Nadia Chabane; Isabelle Roy; Bruno Millet; Marie Christine Mouren-Simeoni; Wolfgang Maier; Thomas Bourgeron; Marion Leboyer
Journal:  Neuroreport       Date:  2004-03-22       Impact factor: 1.837

8.  Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder.

Authors:  David Mataix-Cols; Sarah Wooderson; Natalia Lawrence; Michael J Brammer; Anne Speckens; Mary L Phillips
Journal:  Arch Gen Psychiatry       Date:  2004-06

Review 9.  Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: a decade of advance.

Authors:  Suat Ying Tan Cherlyn; Puay San Woon; Jian Jun Liu; Wei Yi Ong; Guo Chuan Tsai; Kang Sim
Journal:  Neurosci Biobehav Rev       Date:  2010-01-07       Impact factor: 8.989

10.  Orbitofrontal dysfunction in patients with obsessive-compulsive disorder and their unaffected relatives.

Authors:  Samuel R Chamberlain; Lara Menzies; Adam Hampshire; John Suckling; Naomi A Fineberg; Natalia del Campo; Mike Aitken; Kevin Craig; Adrian M Owen; Edward T Bullmore; Trevor W Robbins; Barbara J Sahakian
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

View more
  17 in total

1.  A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.

Authors:  Chen Zhang; Zezhi Li; Zhiguo Wu; Jun Chen; Zuowei Wang; Daihui Peng; Wu Hong; Chengmei Yuan; Zhen Wang; Shunying Yu; Yifeng Xu; Lin Xu; Zeping Xiao; Yiru Fang
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

Review 2.  Rodent models of obsessive compulsive disorder: Evaluating validity to interpret emerging neurobiology.

Authors:  Isaac Zike; Tim Xu; Natalie Hong; Jeremy Veenstra-VanderWeele
Journal:  Neuroscience       Date:  2016-09-16       Impact factor: 3.590

3.  Fronto-Striatal Glutamate in Autism Spectrum Disorder and Obsessive Compulsive Disorder.

Authors:  Jilly Naaijen; Marcel P Zwiers; Houshang Amiri; Steven C R Williams; Sarah Durston; Bob Oranje; Daniel Brandeis; Regina Boecker-Schlier; Matthias Ruf; Isabella Wolf; Tobias Banaschewski; Jeffrey C Glennon; Barbara Franke; Jan K Buitelaar; David J Lythgoe
Journal:  Neuropsychopharmacology       Date:  2016-11-21       Impact factor: 7.853

4.  Identification of a Novel Rat NR2B Subunit Gene Promoter Region Variant and Its Association with Microwave-Induced Neuron Impairment.

Authors:  Li-Feng Wang; Da-Wei Tian; Hai-Juan Li; Ya-Bing Gao; Chang-Zhen Wang; Li Zhao; Hong-Yan Zuo; Ji Dong; Si-Mo Qiao; Yong Zou; Lu Xiong; Hong-Mei Zhou; Yue-Feng Yang; Rui-Yun Peng; Xiang-Jun Hu
Journal:  Mol Neurobiol       Date:  2015-04-28       Impact factor: 5.590

Review 5.  Anxiety and affective disorder comorbidity related to serotonin and other neurotransmitter systems: obsessive-compulsive disorder as an example of overlapping clinical and genetic heterogeneity.

Authors:  Dennis L Murphy; Pablo R Moya; Meredith A Fox; Liza M Rubenstein; Jens R Wendland; Kiara R Timpano
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2013-02-25       Impact factor: 6.237

Review 6.  A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders.

Authors:  Marco A Grados; Elizabeth B Atkins; Gabriela I Kovacikova; Erin McVicar
Journal:  Psychol Res Behav Manag       Date:  2015-04-28

7.  Glutamate Genetics in Obsessive-Compulsive Disorder: A Review.

Authors:  Rageen Rajendram; Sefi Kronenberg; Christie L Burton; Paul D Arnold
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2017-10-01

8.  Therapygenetics: Using genetic markers to predict response to psychological treatment for mood and anxiety disorders.

Authors:  Kathryn J Lester; Thalia C Eley
Journal:  Biol Mood Anxiety Disord       Date:  2013-02-07

9.  Behavioral phenotype in five individuals with de novo mutations within the GRIN2B gene.

Authors:  Inga Freunscht; Bernt Popp; Rainer Blank; Sabine Endele; Ute Moog; Holger Petri; Eva-Christina Prott; Andre Reis; Jochen Rübo; Bernhard Zabel; Martin Zenker; Johannes Hebebrand; Dagmar Wieczorek
Journal:  Behav Brain Funct       Date:  2013-05-29       Impact factor: 3.759

Review 10.  Addressing the Complexity of Tourette's Syndrome through the Use of Animal Models.

Authors:  Ester Nespoli; Francesca Rizzo; Tobias M Boeckers; Bastian Hengerer; Andrea G Ludolph
Journal:  Front Neurosci       Date:  2016-04-08       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.